TOP TIERMARKET NEWSWIRE
Movers explained · 2026-11-18

Archived explainer. For the current picture see today's BEAM page.

Why Is BEAM THERAPEUTICS IN (BEAM) Stock Up Today?

By the Top Tier Newswire AI Desk · November 18, 2026 at 9:43 AM ET · reviewed against 3 wire stories

BEAM THERAPEUTICS IN (BEAM) is up +6.54% in the latest session. Our newswire has captured 3 stories on BEAM across 3 sources in the last 36 hours, with AI sentiment reading mixed (avg 53/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Beam Therapeutics (BEAM) shares rose 6.54% to $22.00, driven by positive topline data from the BEACON Phase 1/2 trial of risto-cel. The company also presented at the UBS Global Biopharma Conference, where executives discussed the updated trial results.

What Happened

Beam Therapeutics announced positive topline pivotal data from the BEACON Phase 1/2 trial of its lead candidate, risto-cel. The company is scheduled to present updated BEACON trial data at the 68th ASH Annual Meeting. During the UBS Global Biopharma Conference, CEO John Evans and other executives provided prepared remarks regarding the clinical progress. The stock also saw new product news, with the company launching the patent-pending BeamHeat product.

What The Data Shows

The stock opened at $21.36, a 3.4% gap up from the prior close of $20.65. It hit a session high of $22.40 at 9:35 AM ET and a low of $20.66 at 9:30 AM ET, closing near $22.15. Volume was 0.2M shares, which is 0.1x the 3-month daily average. The company has a market cap of $2.1B and is unprofitable, with a trailing twelve-month EPS of -1.04 and a net margin of -73.9%. Revenue grew 163.3% over the trailing twelve months. The stock has a beta of 2.22 and a 52-week range of $20.23 to $38.26. Over the last 8 sessions, the stock had fallen 21.8% from $26.41 to $20.65 before this move. The stock printed 7 fresh 52-week highs on 2026-11-18. Recent insider activity includes two sales totaling $1.2M in the last 90 days, with CEO John M. Evans selling on 2026-10-15 and SVP Bethany J Cavanagh selling on 2026-10-01.

What To Watch

Analysts have recently adjusted their views on the stock. Guggenheim maintains a Buy rating with a lowered price target of $51. JonesTrading initiated coverage with a Buy rating, and Wedbush adjusted its price target. Investors will monitor the upcoming presentation of updated BEACON trial data at the 68th ASH Annual Meeting.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

BEAM by the numbers

Last: $22.00Session: +6.54%7 sessions: -22.24%Coverage: 3 stories / 3 sourcesAI sentiment: 53/100 (mixed)Mkt cap: $2.1B52w: $20.23 to $38.26
BEAM · Nov 18 session (5-min) · +3.54% vs prior close · updated 8:53 PM ET
$20.56$21.44$22.32prev close $20.65$21.387:45 AM10:26 AM1:07 PM3:48 PM6:30 PM7:45 AM · $21.007:50 AM · $21.008:05 AM · $20.979:00 AM · $20.949:30 AM · $21.479:35 AM · $22.119:40 AM · $21.989:45 AM · $22.049:50 AM · $21.919:55 AM · $21.9910:00 AM · $22.0410:05 AM · $22.0210:10 AM · $22.0310:15 AM · $22.0110:20 AM · $22.2310:25 AM · $22.0010:30 AM · $21.8510:35 AM · $21.3710:40 AM · $21.4110:45 AM · $21.3110:50 AM · $21.4510:55 AM · $21.3611:00 AM · $21.3111:05 AM · $21.2911:10 AM · $21.3311:15 AM · $21.2511:20 AM · $21.4111:25 AM · $21.5011:30 AM · $21.5511:35 AM · $21.4711:40 AM · $21.4511:45 AM · $21.3911:50 AM · $21.3211:55 AM · $21.4812:00 PM · $21.5212:05 PM · $21.3912:10 PM · $21.4012:15 PM · $21.5512:20 PM · $21.6312:25 PM · $21.6612:30 PM · $21.8712:35 PM · $21.8012:40 PM · $21.8012:45 PM · $21.8312:50 PM · $21.8712:55 PM · $21.901:00 PM · $21.841:05 PM · $21.811:10 PM · $21.681:15 PM · $21.341:20 PM · $21.381:25 PM · $21.391:30 PM · $21.381:35 PM · $21.341:40 PM · $21.341:45 PM · $21.331:50 PM · $21.301:55 PM · $21.332:00 PM · $21.182:05 PM · $21.172:10 PM · $21.222:15 PM · $21.272:20 PM · $21.252:25 PM · $21.252:30 PM · $21.192:35 PM · $21.172:40 PM · $21.132:45 PM · $21.042:50 PM · $21.072:55 PM · $20.963:00 PM · $21.023:05 PM · $20.983:10 PM · $21.043:15 PM · $21.043:20 PM · $20.913:25 PM · $21.033:30 PM · $21.043:35 PM · $21.093:40 PM · $21.043:45 PM · $21.023:50 PM · $21.093:55 PM · $21.024:00 PM · $21.014:15 PM · $21.104:40 PM · $21.126:00 PM · $21.306:30 PM · $21.38
AI sentiment, last 36h · averaged over 3 stories · 53/100 neutral
AI sentiment 53/100 (neutral)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 3 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishThe Fly · sentiment 58 · Beam Global launches patent-pending BeamHeat productThe Fly · 58Beam Global launches patent-pending BeamHeat productSeeking Alpha · sentiment 52 · Beam Therapeutics Inc. (BEAM) Presents at UBS Global Biopharma Conference 2026 Prepared Remarks TranscriptSeeking Alpha · 52Beam Therapeutics Inc. (BEAM) Presents at UBS Global Biopharma Conference 2026 Prepared R…GuruFocus · sentiment 50 · Beam Therapeutics Inc. at UBS Global Biopharma Conference TranscriptGuruFocus · 50Beam Therapeutics Inc. at UBS Global Biopharma Conference Transcript
2d agoGuruFocusNEUTRAL 50General

Beam Therapeutics Inc. at UBS Global Biopharma Conference Transcript

2d agoSeeking AlphaNEUTRAL 52Product/PR

Beam Therapeutics Inc. (BEAM) Presents at UBS Global Biopharma Conference 2026 Prepared Remarks Transcript

Beam Therapeutics Inc. (BEAM) UBS Global Biopharma Conference 2026 November 17, 2026 9:00 AM ESTCompany ParticipantsJohn Evans - CEO &...

3d agoThe FlyBULLISH 58Product/PR

Beam Global launches patent-pending BeamHeat product

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on BEAM: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier BEAM move explainers: 2026-11-18 · 2026-11-10 · 2026-10-29 · 2026-10-28 · 2026-09-09 · 2026-09-08 · 2026-08-26 · 2026-08-25 · 2026-08-20